{"transactions":[{"id":4627795,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21760,"kind":"person","name":"Tamayo Louis Edward","position":1,"cik":"0002083206","reported_name":"Tamayo Louis Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-28T21:15:12.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":54750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest and become exercisable on September 24, 2027, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":54750,"derivative":{"exercise_price":3.39,"expiration_date":"2036-09-23","underlying":"Common Stock","underlying_shares":54750},"source":{"system":"sec-edgar","filing":"0002083206-26-000009","document":"form4-09282026_050908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083206/000208320626000009/form4-09282026_050908.xml","form_type":"4"}},{"id":681799,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21760,"kind":"person","name":"Tamayo Louis Edward","position":1,"cik":"0002083206","reported_name":"Tamayo Louis Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-19T21:00:13.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":4117,"price":4.9071,"value":20202.5307,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.83 to $5.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 78,415 Restricted Stock Units."}],"balance_after":92907,"source":{"system":"sec-edgar","filing":"0002083206-26-000007","document":"form4-08192026_050809.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083206/000208320626000007/form4-08192026_050809.xml","form_type":"4"}},{"id":721631,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21760,"kind":"person","name":"Tamayo Louis Edward","position":1,"cik":"0002083206","reported_name":"Tamayo Louis Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T22:49:38.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":4641,"price":4.49,"value":20838.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of performance Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.33 to $4.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 89,665 RSUs.  Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."}],"balance_after":97024,"source":{"system":"sec-edgar","filing":"0002083206-26-000005","document":"form4-07012026_100733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2083206/000208320626000005/form4-07012026_100733.xml","form_type":"4"}},{"id":721630,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21760,"kind":"person","name":"Tamayo Louis Edward","position":1,"cik":"0002083206","reported_name":"Tamayo Louis Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T22:49:38.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":101665,"source":{"system":"sec-edgar","filing":"0002083206-26-000005","document":"form4-07012026_100733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083206/000208320626000005/form4-07012026_100733.xml","form_type":"4"}},{"id":916293,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21760,"kind":"person","name":"Tamayo Louis Edward","position":1,"cik":"0002083206","reported_name":"Tamayo Louis Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-06T22:00:09.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":226665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option vest and become exercisable on February 4, 2027, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":226665,"derivative":{"exercise_price":7.27,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":226665},"source":{"system":"sec-edgar","filing":"0002083206-26-000002","document":"form4-02062026_050201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2083206/000208320626000002/form4-02062026_050201.xml","form_type":"4"}},{"id":916292,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21760,"kind":"person","name":"Tamayo Louis Edward","position":1,"cik":"0002083206","reported_name":"Tamayo Louis Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-06T22:00:09.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":44665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2027, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported securities are RSUs."}],"balance_after":89665,"source":{"system":"sec-edgar","filing":"0002083206-26-000002","document":"form4-02062026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083206/000208320626000002/form4-02062026_050201.xml","form_type":"4"}},{"id":1050208,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21760,"kind":"person","name":"Tamayo Louis Edward","position":1,"cik":"0002083206","reported_name":"Tamayo Louis Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-03T18:00:05.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option vest and become exercisable on August 15, 2026, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":280000,"derivative":{"exercise_price":4.79,"expiration_date":"2035-08-28","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001415889-25-023491","document":"form4-09032025_020901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2083206/000141588925023491/form4-09032025_020901.xml","form_type":"4"}},{"id":1050207,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21760,"kind":"person","name":"Tamayo Louis Edward","position":1,"cik":"0002083206","reported_name":"Tamayo Louis Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-03T18:00:05.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on August 15, 2026, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported securities are RSUs."}],"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001415889-25-023491","document":"form4-09032025_020901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2083206/000141588925023491/form4-09032025_020901.xml","form_type":"4"}}]}